Apollo Health Ventures
Overview
Early stage investment firm focused on life science and aging therapies.
Deals · 12mo
4
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Bionyra Pharma | Jun 2026Participated | $165 MSeries A | |
Cognito Therapeutics | Mar 2026Participated | $105 MSeries C | |
Aeovian Pharmaceuticals | Dec 2025Participated | $55 MSeries B | |
Scripta Therapeutics | Nov 2025Led | $12 MSeed | |
Still Bright | Jul 2025Participated | $19 MSeed | |
Therini Bio | May 2025Participated | $39 MSeries A | |
HAYA Therapeutics | May 2025Participated | $65 MSeries A | |
Refoxy Pharmaceuticals | Dec 2024Participated | $11 MSeed | |
Booster Therapeutics | Oct 2024Led | $15 MSeed | |
Cleara Biotech | Sep 2022Led | $3 MSeed | |
CLEARA | Sep 2022Led | $3 MSeed | |
Auron Therapeutics | Jul 2022Participated | $48 MSeries A | |
Bionyra Pharma | Jun 2026Participated | $165 MSeries A | |
Cognito Therapeutics | Mar 2026Participated | $105 MSeries C | |
Aeovian Pharmaceuticals | Dec 2025Participated | $55 MSeries B | |
Scripta Therapeutics | Nov 2025Led | $12 MSeed | |
Still Bright | Jul 2025Participated | $19 MSeed | |
Therini Bio | May 2025Participated | $39 MSeries A | |
HAYA Therapeutics | May 2025Participated | $65 MSeries A | |
Refoxy Pharmaceuticals | Dec 2024Participated | $11 MSeed | |
Booster Therapeutics | Oct 2024Led | $15 MSeed | |
Cleara Biotech | Sep 2022Led | $3 MSeed | |
CLEARA | Sep 2022Led | $3 MSeed | |
Auron Therapeutics | Jul 2022Participated | $48 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 4 | 5 |
| Series A | 0 | 6 |
| Series B | 0 | 1 |
| Series C+ | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Oct '19 | 1 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 1 |
| Jun '21 | 1 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 1 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 2 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 1 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 2 |
| Jun '25 | 0 |
| Jul '25 | 1 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 1 |
| Dec '25 | 1 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 1 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 15 |
| Manufacturing | 1 |
| Clean Energy & Sustainability | 1 |
| Data, Analytics & IT | 1 |
| Space & Frontier Tech | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 2 |
| $5M-$10M | 2 |
| $10M-$25M | 6 |
| $25M-$50M | 3 |
| $50M-$100M | 2 |
| $100M-$250M | 2 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 9 |
| United States | 8 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| 4See Ventures | 3 |
| BERNINA BioInvest | 3 |
| Eli Lilly and Company | 3 |
| Arkin Bio Ventures | 2 |
| Broadview Ventures | 2 |
| Curie Capital | 2 |
| Longevity Tech Fund | 2 |
| ROM Utrecht Region | 2 |
| Sanofi Ventures | 2 |
| Schroder Adveq | 2 |
| Sofinnova Partners | 2 |
| Sofinnova Ventures | 2 |
| venBio Partners | 2 |
| Viva BioInnovator | 2 |
| AlbionVC | 1 |
| Alexandria Venture Investments | 1 |
| ALS Investment Fund | 1 |
| Angelini Ventures | 1 |
| ATHOS | 1 |
| Backed | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 4 | 24% |
| Participating | 13 | 76% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 50% |
| Co-led | 2 | 50% |
Team
Co-Founder, Investment Director and Head of VentureLabs
Managing Partner
Partner
Co-Founder and Managing Director
Co-Founder and Head of HR
Venture Development Manager